Risk factors and characteristics associated with uncontrolled severe asthma in patients with aspirin-exacerbated respiratory disease

被引：0

作者：

Mitsui, C. ^{[1
]}

Taniguchi, M. ^{[1
]}

Fukutomi, Y. ^{[1
]}

Higashi, N. ^{[1
]}

Ono, E. ^{[1
]}

Kajiwara, K. ^{[1
]}

Tanimoto, H. ^{[1
]}

Oshikata, C. ^{[1
]}

Sekiya, K. ^{[1
]}

Tsuburai, T. ^{[1
]}

Tsurikisawa, N. ^{[1
]}

Ishii, T. ^{[1
]}

Mori, A. ^{[1
]}

Mita, H. ^{[1
]}

Hasegawa, M. ^{[1
]}

Akiyama, K. ^{[1
]}

机构：

[1] Sagamihara Natl Hosp, Dept Allergy, Sagamihara, Kanagawa, Japan

来源：

ALLERGY | 2011年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

939

引用

页码：364 / 364

页数：1

共 50 条

[21] Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report
C. Caruso
S. Colantuono
D. Pugliese
C. Di Mario
B. Tolusso
E. Gremese
G. Papparella
F. Castrì
A. Gasbarrini
A. Romano
A. Armuzzi
Allergy, Asthma & Clinical Immunology, 16
[22] Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report
Caruso, C.
Colantuono, S.
Pugliese, D.
Di Mario, C.
Tolusso, B.
Gremese, E.
Papparella, G.
Castri, F.
Gasbarrini, A.
Romano, A.
Armuzzi, A.
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
[23] Dysbiosis in aspirin-exacerbated respiratory disease
Cook, Kevin A.
Domissy, Alain
Simon, Ronald A.
White, Andrew A.
Modena, Brian D.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (07) : 1116 - 1120
[24] Aspirin-exacerbated Respiratory Disease (AERD)
Klimek, Ludger
ALLERGOLOGIE, 2014, 37 (01) : 2 - 3
[25] Aspirin-Exacerbated Respiratory Disease REPLY
White, Andrew A.
Stevenson, Donald D.
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23): : 2281 - 2282
[26] Pathogenesis of aspirin-exacerbated respiratory disease
Donald D. Stevenson
Bruce L. Zuraw
Clinical Reviews in Allergy & Immunology, 2003, 24 : 169 - 187
[27] OUTCOMES OF PATIENTS WITH ASPIRIN-EXACERBATED RESPIRATORY DISEASE ON OMALIZUMAB
Jean, T.
Eng, V.
Sheikh, J.
Samant, S.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S14 - S14
[28] Update on Aspirin-Exacerbated Respiratory Disease
Woessner, Katharine M.
CURRENT ALLERGY AND ASTHMA REPORTS, 2017, 17 (01)
[29] Aspirin-exacerbated respiratory disease: A review
Dominas, Christine
Gadkaree, Shekhar
Maxfield, Alice Z.
Gray, Stacey T.
Bergmark, Regan W.
LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (03): : 360 - 367
[30] Tolerability to Etoricoxib in Patients With Aspirin-Exacerbated Respiratory Disease
Koschel, D.
Weber, C. Ninck
Hoeffken, G.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2013, 23 (04) : 275 - 280

← 1 2 3 4 5 →